对产前补充剂的批判性评估:它们是否符合标志?
Mayur B Wanjari1, Sampada V Late2, Ranjana Sharma3
1Department of Research and Development, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India.
Journal of family medicine and primary care
|February 16, 2024
概括
产前补充剂支持孕产妇和胎儿的健康,但存在有效性和安全性的担忧. 孕妇应咨询医疗保健提供者,以获得有关适当使用的指导,并确保补充剂的质量.
科学领域:
- 产科和妇科 产科和妇科
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,产前补充剂被广泛使用,以提高母亲的健康状况并支持胎儿的发育.
- 尽管广泛使用,但仍然存在关于这些补充剂的有效性,安全性和监管的重大担忧.
研究的目的:
- 批判性地评估产前补充剂的多样化景观.
- 检查它们的好处,缺点,影响因素和市场存在.
- 提供基于证据的建议,并确定未来的研究需求.
主要方法:
- 关于产前补充剂的现有研究的综合文献综述.
- 对补充剂类型,报告的益处和不良影响的数据分析.
- 对监管框架和行业标准的评估.
主要成果:
- 产前补充剂显示有好处,包括降低出生缺陷的风险和改善胎儿生长.
- 确定的担忧包括不一致的监管,可变剂量和潜在的孕产妇和胎儿伤害.
- 流行品牌及其配方被评估质量和合规性.
结论:
- 产前补充剂提供潜在的优势,但需要仔细考虑成分,剂量和安全性.
- 咨询医疗保健提供者对于关于补充剂使用的知情决策至关重要.
- 剂量和监管的标准化对于确保一致的质量,安全性和有效性至关重要.
更多相关视频
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Vitamins
721
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
721


